Korean Circ J.  2018 Aug;48(8):692-704. 10.4070/kcj.2018.0231.

Left Atrial Appendages Occlusion: Current Status and Prospective

Affiliations
  • 1Kansas City Heart Rhythm Institute, Overland Park, KS, USA. dlakkireddy@kchrf.org

Abstract

Stroke continues to be a major cause of morbidity and mortality in atrial fibrillation (AF) patients. Oral anticoagulation (OAC) provides protection against stroke and peripheral embolization in AF but significant proportion of patients could not be started on anticoagulation because of bleeding complications. Left atrial appendage harbors clot in about 90% of nonvalvular AF. The advent of left atrial appendage occlusion (LAAO) techniques has provided these patients with alternative to OAC for stroke prophylaxis. Multiple LAAO devices are currently available with Watchman and Amulet being the most commonly used in clinical practice. Randomized studies are available for Watchman device only. Data on Amplatzer Cardiac Plug, Amulet and Lariat devices are limited by the paucity of randomized data. Long-term data on different LAAO techniques are showing promising results. Device related thrombosis continues to be a serious complication associated with LAAO. Future studies should look into comparative effectiveness between different LAAO techniques, optimal patient selection, risk of complications, and anticoagulant treatment after LAAO. This article aims to provide current available evidence on efficacy and safety of different LAAO devices and future prospective.

Keyword

Left atrial appendage occlusion; Atrial fibrillation; Watchman; Amulet; Lariat

MeSH Terms

Atrial Appendage*
Atrial Fibrillation
Hemorrhage
Humans
Mortality
Patient Selection
Prospective Studies*
Stroke
Thrombosis
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr